Press Release: Prolacta : Prolacta Bioscience Introduces Its First Evidence-Based Feeding Protocol for an Exclusive Human Milk Diet in the NICU

Nutritional Guidance Sets Premature Infants on Track for Healthy Growth and Improved Outcomes DUARTE, Calif., June 14, 2022 /PRNewswire/ -- Prolacta Bioscience®, the world's leading hospital provider of 100% human milk-based nutritional products for critically ill, premature infants,...